Showing 1 - 10 of 2,797
Three months into the COVID-19 outbreak caused by a novel strain of coronavirus (SARS-CoV-2), the world is still in search of an effective therapeutic drug. Experimental drugs developed for other infections, such as Gilead's remdesivir, have been repurposed with unclear success. A recent small...
Persistent link: https://www.econbiz.de/10012837598
Incarceration is a crucial part of the scholarly analysis of crime, but what happens inside penal institutions largely remains a 'black box' (Western, 2021). This paper studies the impact of the new psychoactive substances (NPS) epidemic within prisons. NPS are powerful addictive chemical...
Persistent link: https://www.econbiz.de/10013187198
The 'nanny state' has expanded in recent years. Politicians and bureaucrats have increasingly sought to restrict what individuals are permitted to do with their own bodies on their own property. Prohibitions is a corrective to the prevailing support for such authoritarianism. This collection...
Persistent link: https://www.econbiz.de/10014216017
Objective. Develop and apply new costing methodologies to estimate costs of opioid dependence treatment in countries worldwide. Data Sources/Study Setting. Micro-costing methodology developed and data collected during randomized controlled trial (RCT) involving 126 patients ( July 2003-May 2005)...
Persistent link: https://www.econbiz.de/10014189706
This paper uses an unbanked industry to study the impact of government certification on financial access and growth. Marijuana is considered illegal by the Federal law resulting in high financial access costs. I exploit a unique experiment by Washington State that significantly lowered such...
Persistent link: https://www.econbiz.de/10012909760
Persistent link: https://www.econbiz.de/10003650562
Persistent link: https://www.econbiz.de/10003786692
Persistent link: https://www.econbiz.de/10003427162
Persistent link: https://www.econbiz.de/10008860102
Persistent link: https://www.econbiz.de/10003947972